SARS-CoV-2 NSP13 anticorps (C-Term)
-
- Antigène Voir toutes SARS-CoV-2 NSP13 (HEL) Anticorps
- SARS-CoV-2 NSP13 (HEL) (SARS-CoV-2 Helicase (NSP13) (HEL))
-
Épitope
- C-Term
- Reactivité
- SARS Coronavirus-2 (SARS-CoV-2)
-
Hôte
- Chèvre
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp SARS-CoV-2 NSP13 est non-conjugé
-
Application
- Western Blotting (WB)
- Réactivité croisée (Details)
- Reacts with SARS-CoV-2 protein
- Purification
- Epitope affinity purified
- Immunogène
- Affinity purified recombinant fusion protein using the C-terminal of Nsp13 (residues 500 to stop) and produced in E. coli.
- Isotype
- IgG
-
-
- Indications d'application
- WB:1:500-1:2,000
- Commentaires
-
In lysates of transfected cells with the plasmid containing the sequence used, detects the fusion protein by Western blot.
- Restrictions
- For Research Use only
-
- Concentration
- 3 mg/mL
- Buffer
- PBS, 20 % glycerol and 0.05 % sodium azide
- Agent conservateur
- Sodium azide
- Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Stock
- 4 °C,-20 °C
- Stockage commentaire
- Store at -20 °C for long-term storage. Store at 2-8 °C for up to one month.
-
- Antigène
- SARS-CoV-2 NSP13 (HEL) (SARS-CoV-2 Helicase (NSP13) (HEL))
- Autre désignation
- NSP13 (SARS-CoV-2) (HEL Produits)
- Synonymes
- anticorps pp1ab, anticorps ORF1a polyprotein;ORF1ab polyprotein, anticorps ORF1ab
-